1 Study Coverage
    1.1 Spine Biologics Product Introduction
    1.2 Market by Type
        1.2.1 Global Spine Biologics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Bone Graft
        1.2.3 Bone Graft Substitute
        1.2.4 Platelet Rich Plasma (PRP)
        1.2.5 BMAC (Bone Marrow Aspirate Concentrate)
    1.3 Market by Application
        1.3.1 Global Spine Biologics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Anterior Cervical Discectomy and Fusion
        1.3.3 Posterior Lumbar Interbody Fusion
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Spine Biologics Sales Estimates and Forecasts 2017-2028
    2.2 Global Spine Biologics Revenue Estimates and Forecasts 2017-2028
    2.3 Global Spine Biologics Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Spine Biologics Sales by Region
        2.4.1 Global Spine Biologics Sales by Region (2017-2022)
        2.4.2 Global Sales Spine Biologics by Region (2023-2028)
    2.5 Global Spine Biologics Revenue by Region
        2.5.1 Global Spine Biologics Revenue by Region (2017-2022)
        2.5.2 Global Spine Biologics Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Spine Biologics Sales by Manufacturers
        3.1.1 Global Top Spine Biologics Manufacturers by Sales (2017-2022)
        3.1.2 Global Spine Biologics Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Spine Biologics in 2021
    3.2 Global Spine Biologics Revenue by Manufacturers
        3.2.1 Global Spine Biologics Revenue by Manufacturers (2017-2022)
        3.2.2 Global Spine Biologics Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Spine Biologics Revenue in 2021
    3.3 Global Spine Biologics Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Spine Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Spine Biologics Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Spine Biologics Sales by Type
        4.1.1 Global Spine Biologics Historical Sales by Type (2017-2022)
        4.1.2 Global Spine Biologics Forecasted Sales by Type (2023-2028)
        4.1.3 Global Spine Biologics Sales Market Share by Type (2017-2028)
    4.2 Global Spine Biologics Revenue by Type
        4.2.1 Global Spine Biologics Historical Revenue by Type (2017-2022)
        4.2.2 Global Spine Biologics Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Spine Biologics Revenue Market Share by Type (2017-2028)
    4.3 Global Spine Biologics Price by Type
        4.3.1 Global Spine Biologics Price by Type (2017-2022)
        4.3.2 Global Spine Biologics Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Spine Biologics Sales by Application
        5.1.1 Global Spine Biologics Historical Sales by Application (2017-2022)
        5.1.2 Global Spine Biologics Forecasted Sales by Application (2023-2028)
        5.1.3 Global Spine Biologics Sales Market Share by Application (2017-2028)
    5.2 Global Spine Biologics Revenue by Application
        5.2.1 Global Spine Biologics Historical Revenue by Application (2017-2022)
        5.2.2 Global Spine Biologics Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Spine Biologics Revenue Market Share by Application (2017-2028)
    5.3 Global Spine Biologics Price by Application
        5.3.1 Global Spine Biologics Price by Application (2017-2022)
        5.3.2 Global Spine Biologics Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Spine Biologics Market Size by Type
        6.1.1 North America Spine Biologics Sales by Type (2017-2028)
        6.1.2 North America Spine Biologics Revenue by Type (2017-2028)
    6.2 North America Spine Biologics Market Size by Application
        6.2.1 North America Spine Biologics Sales by Application (2017-2028)
        6.2.2 North America Spine Biologics Revenue by Application (2017-2028)
    6.3 North America Spine Biologics Market Size by Country
        6.3.1 North America Spine Biologics Sales by Country (2017-2028)
        6.3.2 North America Spine Biologics Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Spine Biologics Market Size by Type
        7.1.1 Europe Spine Biologics Sales by Type (2017-2028)
        7.1.2 Europe Spine Biologics Revenue by Type (2017-2028)
    7.2 Europe Spine Biologics Market Size by Application
        7.2.1 Europe Spine Biologics Sales by Application (2017-2028)
        7.2.2 Europe Spine Biologics Revenue by Application (2017-2028)
    7.3 Europe Spine Biologics Market Size by Country
        7.3.1 Europe Spine Biologics Sales by Country (2017-2028)
        7.3.2 Europe Spine Biologics Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Spine Biologics Market Size by Type
        8.1.1 Asia Pacific Spine Biologics Sales by Type (2017-2028)
        8.1.2 Asia Pacific Spine Biologics Revenue by Type (2017-2028)
    8.2 Asia Pacific Spine Biologics Market Size by Application
        8.2.1 Asia Pacific Spine Biologics Sales by Application (2017-2028)
        8.2.2 Asia Pacific Spine Biologics Revenue by Application (2017-2028)
    8.3 Asia Pacific Spine Biologics Market Size by Region
        8.3.1 Asia Pacific Spine Biologics Sales by Region (2017-2028)
        8.3.2 Asia Pacific Spine Biologics Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Spine Biologics Market Size by Type
        9.1.1 Latin America Spine Biologics Sales by Type (2017-2028)
        9.1.2 Latin America Spine Biologics Revenue by Type (2017-2028)
    9.2 Latin America Spine Biologics Market Size by Application
        9.2.1 Latin America Spine Biologics Sales by Application (2017-2028)
        9.2.2 Latin America Spine Biologics Revenue by Application (2017-2028)
    9.3 Latin America Spine Biologics Market Size by Country
        9.3.1 Latin America Spine Biologics Sales by Country (2017-2028)
        9.3.2 Latin America Spine Biologics Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Spine Biologics Market Size by Type
        10.1.1 Middle East and Africa Spine Biologics Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Spine Biologics Revenue by Type (2017-2028)
    10.2 Middle East and Africa Spine Biologics Market Size by Application
        10.2.1 Middle East and Africa Spine Biologics Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Spine Biologics Revenue by Application (2017-2028)
    10.3 Middle East and Africa Spine Biologics Market Size by Country
        10.3.1 Middle East and Africa Spine Biologics Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Spine Biologics Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Medtronic
        11.1.1 Medtronic Corporation Information
        11.1.2 Medtronic Overview
        11.1.3 Medtronic Spine Biologics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Medtronic Spine Biologics Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Medtronic Recent Developments
    11.2 Depuy Synthes
        11.2.1 Depuy Synthes Corporation Information
        11.2.2 Depuy Synthes Overview
        11.2.3 Depuy Synthes Spine Biologics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Depuy Synthes Spine Biologics Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Depuy Synthes Recent Developments
    11.3 Stryker Corporation
        11.3.1 Stryker Corporation Corporation Information
        11.3.2 Stryker Corporation Overview
        11.3.3 Stryker Corporation Spine Biologics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Stryker Corporation Spine Biologics Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Stryker Corporation Recent Developments
    11.4 Nuvasive
        11.4.1 Nuvasive Corporation Information
        11.4.2 Nuvasive Overview
        11.4.3 Nuvasive Spine Biologics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Nuvasive Spine Biologics Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Nuvasive Recent Developments
    11.5 Zimmer Biomet
        11.5.1 Zimmer Biomet Corporation Information
        11.5.2 Zimmer Biomet Overview
        11.5.3 Zimmer Biomet Spine Biologics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Zimmer Biomet Spine Biologics Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Zimmer Biomet Recent Developments
    11.6 Orthofix International
        11.6.1 Orthofix International Corporation Information
        11.6.2 Orthofix International Overview
        11.6.3 Orthofix International Spine Biologics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Orthofix International Spine Biologics Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Orthofix International Recent Developments
    11.7 Globus Medical
        11.7.1 Globus Medical Corporation Information
        11.7.2 Globus Medical Overview
        11.7.3 Globus Medical Spine Biologics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Globus Medical Spine Biologics Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Globus Medical Recent Developments
    11.8 alphatec spine
        11.8.1 alphatec spine Corporation Information
        11.8.2 alphatec spine Overview
        11.8.3 alphatec spine Spine Biologics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 alphatec spine Spine Biologics Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 alphatec spine Recent Developments
    11.9 K2M
        11.9.1 K2M Corporation Information
        11.9.2 K2M Overview
        11.9.3 K2M Spine Biologics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 K2M Spine Biologics Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 K2M Recent Developments
    11.10 Exactech
        11.10.1 Exactech Corporation Information
        11.10.2 Exactech Overview
        11.10.3 Exactech Spine Biologics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Exactech Spine Biologics Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Exactech Recent Developments
    11.11 Wright Medical Technology
        11.11.1 Wright Medical Technology Corporation Information
        11.11.2 Wright Medical Technology Overview
        11.11.3 Wright Medical Technology Spine Biologics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Wright Medical Technology Spine Biologics Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Wright Medical Technology Recent Developments
    11.12 X-Spine
        11.12.1 X-Spine Corporation Information
        11.12.2 X-Spine Overview
        11.12.3 X-Spine Spine Biologics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 X-Spine Spine Biologics Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 X-Spine Recent Developments
    11.13 Nutech
        11.13.1 Nutech Corporation Information
        11.13.2 Nutech Overview
        11.13.3 Nutech Spine Biologics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Nutech Spine Biologics Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Nutech Recent Developments
    11.14 Arthrex
        11.14.1 Arthrex Corporation Information
        11.14.2 Arthrex Overview
        11.14.3 Arthrex Spine Biologics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 Arthrex Spine Biologics Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Arthrex Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Spine Biologics Industry Chain Analysis
    12.2 Spine Biologics Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Spine Biologics Production Mode & Process
    12.4 Spine Biologics Sales and Marketing
        12.4.1 Spine Biologics Sales Channels
        12.4.2 Spine Biologics Distributors
    12.5 Spine Biologics Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Spine Biologics Industry Trends
    13.2 Spine Biologics Market Drivers
    13.3 Spine Biologics Market Challenges
    13.4 Spine Biologics Market Restraints
14 Key Findings in The Global Spine Biologics Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Spine Biologics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Bone Graft
    Table 3. Major Manufacturers of Bone Graft Substitute
    Table 4. Major Manufacturers of Platelet Rich Plasma (PRP)
    Table 5. Major Manufacturers of BMAC (Bone Marrow Aspirate Concentrate)
    Table 6. Global Spine Biologics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Spine Biologics Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Spine Biologics Sales by Region (2017-2022) & (K Units)
    Table 9. Global Spine Biologics Sales Market Share by Region (2017-2022)
    Table 10. Global Spine Biologics Sales by Region (2023-2028) & (K Units)
    Table 11. Global Spine Biologics Sales Market Share by Region (2023-2028)
    Table 12. Global Spine Biologics Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Spine Biologics Revenue Market Share by Region (2017-2022)
    Table 14. Global Spine Biologics Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Spine Biologics Revenue Market Share by Region (2023-2028)
    Table 16. Global Spine Biologics Sales by Manufacturers (2017-2022) & (K Units)
    Table 17. Global Spine Biologics Sales Share by Manufacturers (2017-2022)
    Table 18. Global Spine Biologics Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Spine Biologics Revenue Share by Manufacturers (2017-2022)
    Table 20. Spine Biologics Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 21. Global Spine Biologics Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Spine Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Spine Biologics as of 2021)
    Table 23. Spine Biologics Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Spine Biologics Product Offered
    Table 25. Date of Manufacturers Enter into Spine Biologics Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Spine Biologics Sales by Type (2017-2022) & (K Units)
    Table 28. Global Spine Biologics Sales by Type (2023-2028) & (K Units)
    Table 29. Global Spine Biologics Sales Share by Type (2017-2022)
    Table 30. Global Spine Biologics Sales Share by Type (2023-2028)
    Table 31. Global Spine Biologics Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Spine Biologics Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Spine Biologics Revenue Share by Type (2017-2022)
    Table 34. Global Spine Biologics Revenue Share by Type (2023-2028)
    Table 35. Spine Biologics Price by Type (2017-2022) & (USD/Unit)
    Table 36. Global Spine Biologics Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 37. Global Spine Biologics Sales by Application (2017-2022) & (K Units)
    Table 38. Global Spine Biologics Sales by Application (2023-2028) & (K Units)
    Table 39. Global Spine Biologics Sales Share by Application (2017-2022)
    Table 40. Global Spine Biologics Sales Share by Application (2023-2028)
    Table 41. Global Spine Biologics Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Spine Biologics Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Spine Biologics Revenue Share by Application (2017-2022)
    Table 44. Global Spine Biologics Revenue Share by Application (2023-2028)
    Table 45. Spine Biologics Price by Application (2017-2022) & (USD/Unit)
    Table 46. Global Spine Biologics Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 47. North America Spine Biologics Sales by Type (2017-2022) & (K Units)
    Table 48. North America Spine Biologics Sales by Type (2023-2028) & (K Units)
    Table 49. North America Spine Biologics Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Spine Biologics Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Spine Biologics Sales by Application (2017-2022) & (K Units)
    Table 52. North America Spine Biologics Sales by Application (2023-2028) & (K Units)
    Table 53. North America Spine Biologics Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Spine Biologics Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Spine Biologics Sales by Country (2017-2022) & (K Units)
    Table 56. North America Spine Biologics Sales by Country (2023-2028) & (K Units)
    Table 57. North America Spine Biologics Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Spine Biologics Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Spine Biologics Sales by Type (2017-2022) & (K Units)
    Table 60. Europe Spine Biologics Sales by Type (2023-2028) & (K Units)
    Table 61. Europe Spine Biologics Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Spine Biologics Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Spine Biologics Sales by Application (2017-2022) & (K Units)
    Table 64. Europe Spine Biologics Sales by Application (2023-2028) & (K Units)
    Table 65. Europe Spine Biologics Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Spine Biologics Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Spine Biologics Sales by Country (2017-2022) & (K Units)
    Table 68. Europe Spine Biologics Sales by Country (2023-2028) & (K Units)
    Table 69. Europe Spine Biologics Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Spine Biologics Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Spine Biologics Sales by Type (2017-2022) & (K Units)
    Table 72. Asia Pacific Spine Biologics Sales by Type (2023-2028) & (K Units)
    Table 73. Asia Pacific Spine Biologics Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Spine Biologics Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Spine Biologics Sales by Application (2017-2022) & (K Units)
    Table 76. Asia Pacific Spine Biologics Sales by Application (2023-2028) & (K Units)
    Table 77. Asia Pacific Spine Biologics Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Spine Biologics Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Spine Biologics Sales by Region (2017-2022) & (K Units)
    Table 80. Asia Pacific Spine Biologics Sales by Region (2023-2028) & (K Units)
    Table 81. Asia Pacific Spine Biologics Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Spine Biologics Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Spine Biologics Sales by Type (2017-2022) & (K Units)
    Table 84. Latin America Spine Biologics Sales by Type (2023-2028) & (K Units)
    Table 85. Latin America Spine Biologics Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Spine Biologics Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Spine Biologics Sales by Application (2017-2022) & (K Units)
    Table 88. Latin America Spine Biologics Sales by Application (2023-2028) & (K Units)
    Table 89. Latin America Spine Biologics Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Spine Biologics Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Spine Biologics Sales by Country (2017-2022) & (K Units)
    Table 92. Latin America Spine Biologics Sales by Country (2023-2028) & (K Units)
    Table 93. Latin America Spine Biologics Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Spine Biologics Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Spine Biologics Sales by Type (2017-2022) & (K Units)
    Table 96. Middle East and Africa Spine Biologics Sales by Type (2023-2028) & (K Units)
    Table 97. Middle East and Africa Spine Biologics Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Spine Biologics Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Spine Biologics Sales by Application (2017-2022) & (K Units)
    Table 100. Middle East and Africa Spine Biologics Sales by Application (2023-2028) & (K Units)
    Table 101. Middle East and Africa Spine Biologics Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Spine Biologics Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Spine Biologics Sales by Country (2017-2022) & (K Units)
    Table 104. Middle East and Africa Spine Biologics Sales by Country (2023-2028) & (K Units)
    Table 105. Middle East and Africa Spine Biologics Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Spine Biologics Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Medtronic Corporation Information
    Table 108. Medtronic Description and Major Businesses
    Table 109. Medtronic Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 110. Medtronic Spine Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Medtronic Recent Developments
    Table 112. Depuy Synthes Corporation Information
    Table 113. Depuy Synthes Description and Major Businesses
    Table 114. Depuy Synthes Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 115. Depuy Synthes Spine Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Depuy Synthes Recent Developments
    Table 117. Stryker Corporation Corporation Information
    Table 118. Stryker Corporation Description and Major Businesses
    Table 119. Stryker Corporation Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 120. Stryker Corporation Spine Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Stryker Corporation Recent Developments
    Table 122. Nuvasive Corporation Information
    Table 123. Nuvasive Description and Major Businesses
    Table 124. Nuvasive Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 125. Nuvasive Spine Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Nuvasive Recent Developments
    Table 127. Zimmer Biomet Corporation Information
    Table 128. Zimmer Biomet Description and Major Businesses
    Table 129. Zimmer Biomet Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 130. Zimmer Biomet Spine Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Zimmer Biomet Recent Developments
    Table 132. Orthofix International Corporation Information
    Table 133. Orthofix International Description and Major Businesses
    Table 134. Orthofix International Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 135. Orthofix International Spine Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Orthofix International Recent Developments
    Table 137. Globus Medical Corporation Information
    Table 138. Globus Medical Description and Major Businesses
    Table 139. Globus Medical Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 140. Globus Medical Spine Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Globus Medical Recent Developments
    Table 142. alphatec spine Corporation Information
    Table 143. alphatec spine Description and Major Businesses
    Table 144. alphatec spine Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 145. alphatec spine Spine Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. alphatec spine Recent Developments
    Table 147. K2M Corporation Information
    Table 148. K2M Description and Major Businesses
    Table 149. K2M Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 150. K2M Spine Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. K2M Recent Developments
    Table 152. Exactech Corporation Information
    Table 153. Exactech Description and Major Businesses
    Table 154. Exactech Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 155. Exactech Spine Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Exactech Recent Developments
    Table 157. Wright Medical Technology Corporation Information
    Table 158. Wright Medical Technology Description and Major Businesses
    Table 159. Wright Medical Technology Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 160. Wright Medical Technology Spine Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. Wright Medical Technology Recent Developments
    Table 162. X-Spine Corporation Information
    Table 163. X-Spine Description and Major Businesses
    Table 164. X-Spine Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 165. X-Spine Spine Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 166. X-Spine Recent Developments
    Table 167. Nutech Corporation Information
    Table 168. Nutech Description and Major Businesses
    Table 169. Nutech Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 170. Nutech Spine Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 171. Nutech Recent Developments
    Table 172. Arthrex Corporation Information
    Table 173. Arthrex Description and Major Businesses
    Table 174. Arthrex Spine Biologics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 175. Arthrex Spine Biologics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 176. Arthrex Recent Developments
    Table 177. Key Raw Materials Lists
    Table 178. Raw Materials Key Suppliers Lists
    Table 179. Spine Biologics Distributors List
    Table 180. Spine Biologics Customers List
    Table 181. Spine Biologics Market Trends
    Table 182. Spine Biologics Market Drivers
    Table 183. Spine Biologics Market Challenges
    Table 184. Spine Biologics Market Restraints
    Table 185. Research Programs/Design for This Report
    Table 186. Key Data Information from Secondary Sources
    Table 187. Key Data Information from Primary Sources
List of Figures
    Figure 1. Spine Biologics Product Picture
    Figure 3. Global Spine Biologics Market Share by Type in 2021 & 2028
    Figure 3. Bone Graft Product Picture
    Figure 4. Bone Graft Substitute Product Picture
    Figure 5. Platelet Rich Plasma (PRP) Product Picture
    Figure 6. BMAC (Bone Marrow Aspirate Concentrate) Product Picture
    Figure 7. Global Spine Biologics Market Share by Application in 2021 & 2028
    Figure 8. Anterior Cervical Discectomy and Fusion
    Figure 9. Posterior Lumbar Interbody Fusion
    Figure 10. Others
    Figure 11. Spine Biologics Report Years Considered
    Figure 12. Global Spine Biologics Sales 2017-2028 (K Units)
    Figure 13. Global Spine Biologics Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Spine Biologics Revenue 2017-2028 (US$ Million)
    Figure 15. Global Spine Biologics Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Spine Biologics Sales Market Share by Region (2017-2022)
    Figure 17. Global Spine Biologics Sales Market Share by Region (2023-2028)
    Figure 18. North America Spine Biologics Sales YoY (2017-2028) & (K Units)
    Figure 19. North America Spine Biologics Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Spine Biologics Sales YoY (2017-2028) & (K Units)
    Figure 21. Europe Spine Biologics Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Spine Biologics Sales YoY (2017-2028) & (K Units)
    Figure 23. Asia-Pacific Spine Biologics Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Spine Biologics Sales YoY (2017-2028) & (K Units)
    Figure 25. Latin America Spine Biologics Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Spine Biologics Sales YoY (2017-2028) & (K Units)
    Figure 27. Middle East & Africa Spine Biologics Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Spine Biologics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Spine Biologics in the World: Market Share by Spine Biologics Revenue in 2021
    Figure 30. Global Spine Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Spine Biologics Sales Market Share by Type (2017-2028)
    Figure 32. Global Spine Biologics Revenue Market Share by Type (2017-2028)
    Figure 33. Global Spine Biologics Sales Market Share by Application (2017-2028)
    Figure 34. Global Spine Biologics Revenue Market Share by Application (2017-2028)
    Figure 35. North America Spine Biologics Sales Market Share by Type (2017-2028)
    Figure 36. North America Spine Biologics Revenue Market Share by Type (2017-2028)
    Figure 37. North America Spine Biologics Sales Market Share by Application (2017-2028)
    Figure 38. North America Spine Biologics Revenue Market Share by Application (2017-2028)
    Figure 39. North America Spine Biologics Sales Share by Country (2017-2028)
    Figure 40. North America Spine Biologics Revenue Share by Country (2017-2028)
    Figure 41. U.S. Spine Biologics Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Spine Biologics Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Spine Biologics Sales Market Share by Type (2017-2028)
    Figure 44. Europe Spine Biologics Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Spine Biologics Sales Market Share by Application (2017-2028)
    Figure 46. Europe Spine Biologics Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Spine Biologics Sales Share by Country (2017-2028)
    Figure 48. Europe Spine Biologics Revenue Share by Country (2017-2028)
    Figure 49. Germany Spine Biologics Revenue (2017-2028) & (US$ Million)
    Figure 50. France Spine Biologics Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Spine Biologics Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Spine Biologics Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Spine Biologics Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Spine Biologics Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Spine Biologics Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Spine Biologics Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Spine Biologics Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Spine Biologics Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Spine Biologics Revenue Share by Region (2017-2028)
    Figure 60. China Spine Biologics Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Spine Biologics Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Spine Biologics Revenue (2017-2028) & (US$ Million)
    Figure 63. India Spine Biologics Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Spine Biologics Revenue (2017-2028) & (US$ Million)
    Figure 65. China Taiwan Spine Biologics Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Spine Biologics Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Spine Biologics Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Spine Biologics Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Spine Biologics Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Spine Biologics Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Spine Biologics Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Spine Biologics Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Spine Biologics Sales Share by Country (2017-2028)
    Figure 74. Latin America Spine Biologics Revenue Share by Country (2017-2028)
    Figure 75. Mexico Spine Biologics Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Spine Biologics Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Spine Biologics Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Spine Biologics Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Spine Biologics Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Spine Biologics Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Spine Biologics Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Spine Biologics Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Spine Biologics Revenue Share by Country (2017-2028)
    Figure 84. Turkey Spine Biologics Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Spine Biologics Revenue (2017-2028) & (US$ Million)
    Figure 86. UAE Spine Biologics Revenue (2017-2028) & (US$ Million)
    Figure 87. Spine Biologics Value Chain
    Figure 88. Spine Biologics Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed